China’s Ping An buys stake in Japanese herbal drugs firm

The Chinese insurer and Japan’s Tsumura will jointly make and sell the latter's traditional medicine products in China.

Ping An Insurance is buying a 10% stake in Tsumura, which makes and sells Japanese herbal medicine, known as kampo drugs. 

Kampo has its roots in Chinese culture, and now the insurance company is reuniting the two branches of traditional medicine.

Together, Ping An and Tsumura will form a joint venture in China to combine the secrets of kampo with traditional Chinese medicine, from cultivation of herbs to the final product.

Chinese consumers’ growing emphasis on wellness is creating a wave of new investment opportunities.The cultural shift is transforming swathes of industry demand for vitamins has sparked a wave of Chinese outbound...

¬ Haymarket Media Limited. All rights reserved.

FinanceAsia has updated its subscription model.

Registered readers now have the opportunity to read 5 articles from our award-winning website for free.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team (2-10 users), or office-wide licences.

To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222

Article limit is reached.

Hello! You have used up all of your free articles on FinanceAsia.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team (2-10 users), or office-wide licences. To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222